Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer

Yasmin Leshem*, Yardenna Dolev, Nava Siegelmann-Danieli, Sarah Sharman Moser, Lior Apter, Gabriel Chodick, Alla Nikolaevski-Berlin, Sivan Shamai, Ofer Merimsky, Ido Wolf*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences